Status:

COMPLETED

Tachikawa Project for Prevention of Posttraumatic Stress Disorder With Polyunsaturated Fatty Acid (TPOP): TPOP-02 Study

Lead Sponsor:

Japan Science and Technology Agency

Collaborating Sponsors:

University of Toyama

Chiba University

Conditions:

Trauma

Posttraumatic Stress Disorder

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate efficacy and safety of Polyunsaturated Fatty Acid for the prevention of Posttraumatic Stress Disorder (PTSD) in patients with accidental injuries.

Detailed Description

Accidental injuries, mostly motor vehicle accident, in civilian population are frequent events.For instance, nearly one-third of injured patients appear to develop trauma-related psychiatric illness a...

Eligibility Criteria

Inclusion

  • 18 plus years
  • A native Japanese speaking ability
  • Possibility to contact patients with injury in 240 hours, and dosing in oral use
  • Physical and metal status to possible understands scope and contents in the trial and gets informed consent

Exclusion

  • Clearly irretrievable acute brain parenchyma damage and subdural or subarachnoidal bleeding detected by computed tomography and/or magnetic resonance imaging
  • Cognitive impairment: Mini Mental State Examination \< 24
  • Heavy drinker or 100IU/L ≦ γGTP in administration
  • Heavy smoker (over 40 cigarettes per day)
  • History and current suspicion in diagnosis of psychosis and bipolar I disorder
  • Suspicion in diagnosis of alcoholic, substance-related disorder and eating disorder
  • Existence of marked serious symptoms such as suicidal ideation, self-harm behavior, dissociation, status of need rapidly psychiatric treatment
  • Use of anti-epilepsy drug, lithium, ethyl icosapentate and anti-coagulant drug (for example, aspirin, warfarin, etc) within 3 month at regular intervals
  • Use of polyunsaturated fatty acid supplement within 3 month at regular intervals
  • Habit of eating fish over 4 times per week

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2013

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT00671099

Start Date

December 1 2008

End Date

December 1 2013

Last Update

January 22 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Disaster Medical Center

Tachikawa, Tokyo, Japan, 1900014